July 27, 2003
I have set up a dissolution forum on this website. It is simply called dissolution talk. You can visit it here. You may post as a guest to some subject. But signing up is fast a simple, why not use the name you are already using for other forums. You also have the option to change your forum name in the future if you so choose.
Some of you may wonder why I set up a new forum for the discussion of dissolution and related pharmaceutical analysis. My reply is that many have asked me to set up something that is independent from the manufacturers control.
This give us several advantages that a manufacturer can not supply. One of the first advantages is that It allows us to review and critique the equipment that is available without censoring. Another advantage is that all sides can be represented without unbalanced or unfair representation. Some have contacted me and informed me that they have been locked out and denied viewing privilege from the other board.
I myself have had comments deleted. Once I asked the question "What happened to SFA?" (that was all I posted, SFA is a dissolution company that shut down a few years ago.) For some reason, my post was deleted and I was never informed why.
So, I decided as an experiment to set this up. If it works, Great. If it does not, then at least I tried. Please e-mail everyone you know and ask them to visit the forum on the dissolution solutions network.
July 25, 2003
Inhaler Aspirair works faster than Viagra
"Viagra faces a new challenge after succesful tests of an inhaler that works faster than the blue pill.
The Aspirair device, similar to an asthma inhaler, administers apomorphine to tackle erectile dysfunction. Because the drug is breathed in, it hits the bloodstream more quickly and delivers a swifter response. Viagra, which is swallowed, can take up to an hour to work... more"
July 23, 2003
Abbott unit plans guilty plea in investigation
" A subsidiary of U.S. drugmaker Abbott Laboratories Inc. plans to plead guilty on Wednesday to obstructing a criminal investigation of possible health-care offences that defrauded government insurance programs, The Wall Street Journal reported on Wednesday. more..."
19 Indicted in Prescription Drug Fraud
"A Florida grand jury investigating pharmaceutical wholesalers indicted 19 people on charges of peddling bogus or diluted medications often prescribed for cancer and AIDS patients, authorities said Monday.
Investigators said the defendants made tens of millions of dollars from the scheme, and that bogus drugs eventually found their way into common chains in Florida such as Walgreen's and Eckerd drug stores. more..."
July 14, 2003
Tomorrow's PC -- Smaller, Faster, Works Even When Turned Off
"Dell made headlines by announcing it would begin phasing out, in its high-end desktops, a component that disappeared from many notebooks, Macs, and users' radar screens two years ago: the 1.44MB floppy drive. For transferring files between computers, Dell says, pocket or key-fob flash-memory drives that plug into USB ports offer superior capacity (as much as 512MB) and convenience.
I agree -- I use a 64MB flash gadget to move documents, screen grabs, and software downloads among various PCs, and you'll pry it from my cold, dead hands -- though I'll also admit flash drives cost a fortune compared to floppies (prices start at $35 or $40 for 32MB units). Blank CDs have gotten cheap, but has anyone noticed... "
July 11, 2003
SPECIAL NOTE: NEWS SPOTTERS NEEDED
We have a need for news spotters. We have one, but we need even more. If you have interest in sending your links, news, tips troubleshooting techniques, articles, and web sites which you discover, please send me an email and I'll explain what to do. You'll get your name added as one of DSN News Spotters.
A strategy to reduce cardiovascular disease by more than 80%
Objectives: To determine the combination of drugs and vitamins, and their doses, for use in a single daily pill to achieve a large effect in preventing cardiovascular disease with minimal adverse effects more...
July 10, 2003
"Alnylam Pharmaceuticals, Ribopharma of Germany merge- Privately held Alnylam Pharmaceuticals Inc. and Ribopharma AG of Germany said Monday they have merged.
Both companies are developing RNA interference, a technique that deactivates, or "silences," genes. Pharmaceutical firms already use it to identify the role played by specific genes in regulating biological activity, and biotech concerns want to use the technique to discover new drugs.
The combined company will be called Alnylam Holding Co"
"Schering-Plough Corporation announced a new organizational structurefor its Global Pharmaceutical Business, consolidating several previously autonomous prescription pharmaceutical business units into a unified, globally integrated operation ..."
July 9, 2003
Yes, We were down for the 4th of July weekend. Seems that Our server in Florida went down, I had to relocate to a more reliable server in California. Everything is back to normal, new location,same site, but you'd never know if I hadn't told you.